61
Participants
Start Date
November 3, 2016
Primary Completion Date
June 21, 2019
Study Completion Date
July 1, 2019
Natalizumab
Extending dose intervals of natalizumab from 4 weeks to maximum of 8 weeks based on trough natalizumab concentrations
OLVG, Amsterdam
VU medical center, Amsterdam
Rijnstate Hospital, Arnhem
Erasmus medical center, Rotterdam
St. Antonius Hospital, Utrecht
Collaborators (2)
Prothya Biosolutions
INDUSTRY
Erasmus Medical Center
OTHER
St. Antonius Hospital
OTHER
OLVG
NETWORK
Rijnstate Hospital
OTHER
Amsterdam UMC, location VUmc
OTHER